3',4'-dihydroxyflavone has been researched along with quercetin in 13 studies
| Studies (3',4'-dihydroxyflavone) | Trials (3',4'-dihydroxyflavone) | Recent Studies (post-2010) (3',4'-dihydroxyflavone) | Studies (quercetin) | Trials (quercetin) | Recent Studies (post-2010) (quercetin) |
|---|---|---|---|---|---|
| 31 | 0 | 14 | 12,403 | 239 | 7,510 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Guinea, M; Parellada, J | 1 |
| Hong, C; Jeong, S; Kim, KH; Lee, J; Park, T | 1 |
| Debyser, Z; Glisic, S; Mouscadet, JF; Veljkovic, N; Veljkovic, V | 1 |
| Gavande, N; Hanrahan, JR; Hibbs, DE; Kim, MS; Matin, A; Roubin, RH; Salam, NK; Yang, NX | 1 |
| Kogami, Y; Matsuda, H; Nakamura, S; Sugiyama, T; Ueno, T; Yoshikawa, M | 1 |
| Fernandes, E; Freitas, M; Porto, G; Ribeiro, D; Silva, AM; Tomé, SM | 1 |
| Cabrita, EJ; Fernandes, E; Freitas, M; Marques, MM; Porto, G; Ribeiro, D; Silva, AM; Tomé, SM | 1 |
| Chakraborty, A; Chakraborty, M; Frye, SV; Gu, C; Pearce, KH; Puhl-Rubio, AC; Shears, SB; Stashko, MA; Wang, H; Wang, X | 1 |
| Abe, H; Adachi, I; Horino, Y; Kesamaru, H; Nose, T; Suyama, K; Tomohara, K | 1 |
| Fernandes, E; Fernandes, PA; Freitas, M; Oliveira, A; Proença, C; Ramos, MJ; Ribeiro, D; Silva, AMS; Sousa, JLC | 1 |
| Albiñana, CB; Brynda, J; Fanfrlík, J; Flieger, M; Hodek, J; Karlukova, E; Konvalinka, J; Kožíšek, M; Machara, A; Majer, P; Radilová, K; Weber, J; Zima, V | 1 |
| Awad, HM; Boeren, S; Boersma, MG; Rietjens, IM; van Bladeren, PJ; Vervoort, J | 1 |
| Alhazza, IM; Alwasel, SH; Hudecova, L; Jomová, K; Lauro, P; Simunkova, M; Valko, M | 1 |
13 other study(ies) available for 3',4'-dihydroxyflavone and quercetin
| Article | Year |
|---|---|
Flavonoid inhibitors of trypsin and leucine aminopeptidase: a proposed mathematical model for IC50 estimation.
Topics: Flavonoids; Kinetics; Leucyl Aminopeptidase; Models, Biological; Regression Analysis; Structure-Activity Relationship; Trypsin Inhibitors | 1995 |
3-Hydroxychromones as cyclin-dependent kinase inhibitors: synthesis and biological evaluation.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Survival; Chromones; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor Proteins; Humans; Inhibitory Concentration 50; Protein Binding; Structure-Activity Relationship | 2007 |
Simple criterion for selection of flavonoid compounds with anti-HIV activity.
Topics: Anti-HIV Agents; Computational Biology; Flavonoids; Humans; Models, Molecular; Quantitative Structure-Activity Relationship | 2007 |
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.
Topics: Benzopyrans; Cell Line; Humans; PPAR alpha; PPAR gamma; Structure-Activity Relationship | 2009 |
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
Topics: 3T3-L1 Cells; Adipogenesis; Animals; CCAAT-Enhancer-Binding Protein-alpha; CCAAT-Enhancer-Binding Protein-beta; CCAAT-Enhancer-Binding Protein-delta; Deoxyglucose; Fatty Acid-Binding Proteins; Flavonoids; Glucose Transporter Type 4; Mice; PPAR gamma; Structure-Activity Relationship | 2011 |
Modulation of human neutrophils' oxidative burst by flavonoids.
Topics: Flavonoids; Humans; Luminescent Measurements; Molecular Structure; Neutrophils; Oxidation-Reduction | 2013 |
Inhibition of LOX by flavonoids: a structure-activity relationship study.
Topics: Dose-Response Relationship, Drug; Flavonoids; Glycine max; Humans; Leukotriene B4; Lipoxygenase; Molecular Structure; Neutrophils; Structure-Activity Relationship | 2014 |
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
Topics: Binding Sites; Crystallography, X-Ray; HCT116 Cells; Humans; Inositol Phosphates; Molecular Structure; Phosphotransferases (Alcohol Group Acceptor); Phosphotransferases (Phosphate Group Acceptor); Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quercetin; Structure-Activity Relationship | 2019 |
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
Topics: | 2019 |
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
Topics: Drug Design; Enzyme Inhibitors; Flavonoids; Fructose; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Liver; Molecular Structure | 2020 |
Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
Topics: Antiviral Agents; Crystallography, X-Ray; Drug Evaluation, Preclinical; Endonucleases; Enzyme Assays; Enzyme Inhibitors; Flavonoids; Influenza A virus; Microbial Sensitivity Tests; Molecular Structure; Protein Binding; Protein Domains; RNA-Dependent RNA Polymerase; Structure-Activity Relationship; Viral Proteins | 2020 |
The regioselectivity of glutathione adduct formation with flavonoid quinone/quinone methides is pH-dependent.
Topics: Chromatography, High Pressure Liquid; Flavonoids; Flavonols; Glutathione; Hydrogen-Ion Concentration; Indolequinones; Indoles; Luteolin; Magnetic Resonance Spectroscopy; Mass Spectrometry; Quercetin; Quinones | 2002 |
A Switch between Antioxidant and Prooxidant Properties of the Phenolic Compounds Myricetin, Morin, 3',4'-Dihydroxyflavone, Taxifolin and 4-Hydroxy-Coumarin in the Presence of Copper(II) Ions: A Spectroscopic, Absorption Titration and DNA Damage Study.
Topics: Antineoplastic Agents; Antioxidants; Chelating Agents; Copper; Coumarins; DNA Damage; Electron Spin Resonance Spectroscopy; Flavonoids; Humans; Hydroxyl Radical; Ions; Photoelectron Spectroscopy; Polyphenols; Quercetin; Reactive Oxygen Species | 2019 |